http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100310796-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-513 |
| filingDate | 1994-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100310796-B1 |
| titleOfInvention | Neurotrophic Factor Pharmaceutical Formulations |
| abstract | A stable aqueous pharmaceutical combination of human neuronal growth factor (NGF) in an isotonic aqueous solution is buffered to maintain a pH of about 4.5 to about 6.0 and optionally containing a carrier such as human serum albumin. Also provided are aqueous NGF formulations suitable for lyophilization followed by reconstitution, wherein rhNGF is mixed with sugars, optionally HSA, and buffer. This combination is useful for treating Alzheimer's disease and other neuronal disorders. |
| priorityDate | 1992-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.